Presentation Information
[3PS-08-10]Developing novel cancer therapies by targeting epigenetic molecules, including polycomb PRC2
○Hisanori Takenobu1, Yuki Endo2,1, Dilibaerguli Shaliman1,3, Miki Ohira1, Ryuichi P Sugino1, Masayuki Haruta1, Shunpei Satoh1, Jesmin Akter1, Tomoko Wada1, Atsuko Nakazawa4, Takehiko Kamijo1,3 (1. RICO, Saitama Cancer Center, 2. Dept. Pediatric Surgery, Tohoku Univ., 3. Dept. Science and Engineering, Saitama Univ., 4. Dept. Clinical Research, Saitama Children's Medical Center)
Comment
To browse or post comments, you must log in.Log in
